skip to Global Navigation Bar skip to main content


homeHome > R&D > Introducing Labs > Global R&D Centers

Global R&D Centers

  • Global R&D Centers

    Life Science Research Institute (Yongin, South Korea)

    1. 01. New Chemical Entity (NCE)
      - Therapeutic areas: Autoimmune diseases, Metabolic diseases
      - In-vitro/in-vivo evaluation for autoimmune drugs
    2. 02. Incrementally Modified Drugs
      - Sustained-release technologies including Depot
      - Differentiated fixed-dose combination technology
    3. 03. Synthesis technology for high-level APIs such as peptides
  • Global R&D Centers

    Daewoong Bio Center (Yongin, South Korea, Oct. 2016)

    1. 01. Recombinant products including therapeutic antibodies
      - Bio-betters using long-acting technology, Growth factors
    2. 02. Stem cell research for enhancement of efficacy
      - Innovative stem cell line establishment
      - Stem cell bioprocess
      - Discovery of new indications
    3. 03. Development of Botulinum toxin drugs - Next generation toxin
  • Global R&D Centers

    Liaoning Research Center (China, Oct 2014)

    1. 01. Development of generics for China market entry
    2. 02. Formulation R&D
      - New oral solutions, Suspension products, Sustained-release drugs
    3. 03. Academic collaboration (ex.Shenyang Pharmaceutical Univ.)
  • Global R&D Centers

    Hyderabad Research Center (India, Jan 2009)

    1. 01. Development of first generics
    2. 02. Development of global generics for EU/US market entry
      - Sustained-release drugs, Formulation change
  • Global R&D Centers

    Jakarta Research Center (Indonesia, Dec 2016)

    1. 01. Development of biotechnology-driven products
      - EPO, EGF, hGH
      - Extensions of indication through clinical studies
    2. 02. Focus on reverse innovation and open collaboration
      (ex. Univ. of Indonesia)